Myasthenia gravis of the oculomotor type and with thymoma may resolve or heal on its own; most other forms of myasthenia gravis do not resolve, but clinical cure can be achieved.
Myasthenia gravis is an autoimmune disease that is mediated primarily by antibodies against acetylcholine receptors and involves acetylcholine receptors in the postsynaptic membrane.
Clinically, myasthenia gravis can be categorized into adult (including oculomotor, generalized, acute severe, delayed severe, and myasthenia gravis), childhood, and juvenile.
The most common treatments for myasthenia gravis currently include cholinesterase inhibitor therapy, immunosuppressive drug therapy, intravenous gammaglobulin plasma exchange, thymus removal surgery, and thymus radiation therapy. The optimal treatment plan varies for different types and individuals.
① A small number of patients with oculomotor myasthenia gravis are able to recover spontaneously. ② In patients with thymic hypertrophy and high acetylcholine receptor antibody potency, as well as in patients with all types of myasthenia gravis associated with thymoma, thymectomy removes the initiating antigens of the patient’s autoimmune response, and reduces the number of T-cells, B-cells, and cytokines involved in autoimmune response. Approximately 70% of patients experience symptomatic relief or cure after surgery.
Regardless of the treatment modality, myasthenia gravis is virtually incurable except in the cases described above. However, the progression of the disease can be greatly slowed and even clinical cure can be achieved with the right treatment program.
Each patient is different and has different sensitivities to different treatments, which can lead to different outcomes and different prognoses. All of the above treatments should be carried out under the guidance of a doctor, and it is recommended to go to the hospital in time for treatment under the guidance of a doctor if you feel unwell.